Showing results (111-120 of 256) with videos related to
Sort By:
Pageof 26
Annals of the Rheumatic Diseases|May 20, 2005
Double blind, randomised, placebo controlled study of leflunomide in the treatment of active ankylosing spondylitisJ C van Denderen, M van der Paardt, M T Nurmohamed, et al.The Journal of Rheumatology|March 7, 2008
IgM-rheumatoid factor, anti-cyclic citrullinated peptide, and anti-citrullinated human fibrinogen antibodies decrease during treatment with the tumor necrosis factor blocker infliximab in patients with rheumatoid arthritisMarijn Vis, Wouter H Bos, Gertjan Wolbink, et al.Scandinavian Journal of Rheumatology|July 12, 2002
The prevalence of H. pylori is still substantial in rheumatic patientsH T J I de LeesT, K S S Steen, S van Wijngaarden, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 15, 2010
18F-FDG PET as a tool to predict the clinical outcome of infliximab treatment of rheumatoid arthritis: an explorative studyErnst H Elzinga, Conny J van der Laken, Emile F I Comans, et al.Annals of the Rheumatic Diseases|April 9, 2008
Microvascular function is impaired in ankylosing spondylitis and improves after tumour necrosis factor alpha blockadeI C van Eijk, M J L Peters, E H Serné, et al.The Journal of Rheumatology|August 13, 2003
The predictive value of anti-cyclic citrullinated peptide antibodies in early arthritisLouise M A Jansen, Dirkjan van Schaardenburg, Irene van der Horst-Bruinsma, et al.Annals of the Rheumatic Diseases|August 15, 2008
Adalimumab effectiveness for the treatment of ankylosing spondylitis is maintained for up to 2 years: long-term results from the ATLAS trialD van der Heijde, M H Schiff, J Sieper, et al.Arthritis and Rheumatism|September 8, 2011
Macrophage positron emission tomography imaging as a biomarker for preclinical rheumatoid arthritis: findings of a prospective pilot studyYoony Y J Gent, Alexandre E Voskuyl, Reina W Kloet, et al.Seminars in Arthritis and Rheumatism|June 14, 2011
The effect of TNF-alpha blocking therapy on lipid levels in rheumatoid arthritis: a meta-analysisAlper M van Sijl, Mike J L Peters, Dirk L Knol, et al.Rheumatology (Oxford, England)|July 19, 2013
What do we miss? ASAS non-responders on anti-TNF therapy show improvement in performance-based physical functionSalima F E van Weely, J Christiaan van Denderen, Martijn P M Steultjens, et al.Pageof 26